Neurocrine Biosciences Inc. Stock Performance
as on November 7, 2025 at 2:29 am IST
Day's Low
Day's High
$152.86$155.64
1.26%
Downside
0.54%
Upside
52 Week's Low
52 Week's High
$84.23$157.6745.59%
Downside
1.85%
Upside
Neurocrine Biosciences Inc. share price movements today
- Previous Close
- $153.75
- Open
- $153.32
- Volume
- 883.3K
- Day's Low - High
- $152.86 - $155.64
- 52 Week Low - High
- $84.23 - $157.67
Neurocrine Biosciences Inc. Historical Returns
- 1 Month Return
- + 12.99 %
- 3 Month Return
- + 23.25 %
- 1 Year Return
- + 24.86 %
- 3 Year Return
- + 27.88 %
- 5 Year Return
- + 60.68 %
Neurocrine Biosciences Inc. Stock Fundamentals & Key Indicators
Check Neurocrine Biosciences Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$15.3B
EPS (TTM)
6.8913
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.65%
PE Ratio (TTM)
36.69
Industry PE ratio
19.200384615384614
PEG Ratio
0.2733
EBITDA
570.0M
Revenue (TTM)
2.7B
Profit Margin
15.95%
Return On Equity TTM
14.96%
Neurocrine Biosciences Inc. Stock Valuation
Track how Neurocrine Biosciences Inc. P/E has moved over time to understand its valuation trends.
Neurocrine Biosciences Inc. in the last 5 years
Lowest (24.45x)
June 30, 2025
Industry (19.20x)
November 7, 2025
Today (36.69x)
November 7, 2025
Highest (178.01x)
September 30, 2022
Today’s Price to Earnings Ratio: 36.69x
Neurocrine Biosciences Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Neurocrine Biosciences Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $15.3B | 60.68% | 36.69 | 15.95% | |
| BUY | $19.5B | NA | 17.21 | 40.65% | |
| BUY | $41.9B | NA | 21.65 | 13.81% | |
| BUY | $53.4B | -29.36% | 20.77 | 27.83% |
Stock Returns calculator for Neurocrine Biosciences Inc. Stock including INR - Dollar returns
The Neurocrine Biosciences Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Neurocrine Biosciences Inc. investment value today
Current value as on today
₹1,29,974
Returns
₹29,974
(+29.97%)
Returns from Neurocrine Biosciences Inc. Stock
₹24,867 (+24.87%)
Dollar Returns*
₹5,107 (+5.11%)
Analyst Recommendation on Neurocrine Biosciences Inc. Stock
Based on 34 analysts
76.47%
Buy
23.53%
Hold
0.00%
Sell
Based on 34 analysts, 76.47% of analysts recommend a 'BUY' rating for Neurocrine Biosciences Inc.. Average target price of $174.81
Neurocrine Biosciences Inc. Share Price Target
Get share price movements and forecasts by analysts on Neurocrine Biosciences Inc..
What analysts predicted
11.44%UPSIDE
Target Price
$174.81
Current Price
$154.81
Analyzed by
34 Analysts
Target
$174.81
Neurocrine Biosciences Inc. target price $174.81, a slight upside of 11.44% compared to current price of $154.81. According to 34 analysts rating.
Neurocrine Biosciences Inc. Stock’s Investor Sentiment and Interest
Search interest for Neurocrine Biosciences Inc. Stock has increased by 20% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:20% versus previous 30 day period
Neurocrine Biosciences Inc. Quarterly Profit & Loss
All numbers in Millions USD
Neurocrine Biosciences Inc. Annual Profit & Loss
All numbers in Millions USD
Neurocrine Biosciences Inc. Quarterly Cash Flow
All numbers in Millions USD
Neurocrine Biosciences Inc. Annual Cash Flow
All numbers in Millions USD
Neurocrine Biosciences Inc. News & Key Events
Today's Timeline - 27 October
Tue, 02:37 AM
-Neurocrine launches Phase 2 study for crinecerfont in pediatric CAH patients, focusing on pharmacokinetics and safety.
Tue, 02:43 AM
-Neurocrine initiates Phase 3 study for NBI-1065845 in MDD treatment, assessing its efficacy in preventing relapse.
Insights on Neurocrine Biosciences Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 3 quarters, 572.6M → 794.9M (in $), with an average increase of 15.1% per quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, NBIX has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, NBIX has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 7 days, NBIX stock has moved up by 8.1%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, 7.9M → 209.5M (in $), with an average increase of 70.7% per quarter
About Neurocrine Biosciences Inc.
| Organisation | Neurocrine Biosciences Inc. |
| Headquarters | 12780 El Camino Real, San Diego, CA, United States, 92130 |
| Industry | Health Technology |
| CEO | Mr. Kyle W. Gano Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Neurocrine Biosciences Inc.
Name | Title |
|---|---|
Jane Sorensen | Head of Investor Relations |
Mr. Kyle W. Gano Ph.D. | CEO & Director |
Dr. Jude Onyia Ph.D. | Chief Scientific Officer |
Dr. Eiry Wyn Roberts M.D. | Strategic Advisor |
Dr. Wylie W. Vale Ph.D. | Co-Founder |
Dr. Lawrence Steinman BA, M.D., Ph.D. | Co-Founder of Neurocrine |
Mr. Lewis Choi | Chief Information Officer |
Mr. Matthew C. Abernethy CPA | Chief Financial Officer |
Mr. Eric S. Benevich | Chief Commercial Officer |
Mr. Darin M. Lippoldt Esq. | Chief Legal Officer & Corporate Secretary |
FAQs
What is Neurocrine Biosciences Inc. share price today?
Neurocrine Biosciences Inc. share price today is $154.81 as on at the close of the market. Neurocrine Biosciences Inc. share today touched a day high of $155.64 and a low of $152.86.
What is the 52 week high and 52 week low for Neurocrine Biosciences Inc. share?
Neurocrine Biosciences Inc. share touched a 52 week high of $157.67 on and a 52 week low of $84.23 on . Neurocrine Biosciences Inc. stock price today i.e. is closed at $154.81,which is 1.81% down from its 52 week high and 83.79% up from its 52 week low.
What is Neurocrine Biosciences Inc.'s market capitalisation today?
Neurocrine Biosciences Inc. market capitalisation is $0.02T as on .
How to invest in Neurocrine Biosciences Inc. Stock (NBIX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Neurocrine Biosciences Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Neurocrine Biosciences Inc. Shares that will get you 0.0097 shares as per Neurocrine Biosciences Inc. share price of $154.81 per share as on November 7, 2025 at 2:29 am IST.
What is the minimum amount required to buy Neurocrine Biosciences Inc. Stock (NBIX) from India?
Indian investors can start investing in Neurocrine Biosciences Inc. (NBIX) shares with as little as ₹88.626 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.26 in Neurocrine Biosciences Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Neurocrine Biosciences Inc. share’s latest price of $154.81 as on November 7, 2025 at 2:29 am IST, you will get 0.0646 shares of Neurocrine Biosciences Inc.. Learn more about
fractional shares .
What are the returns that Neurocrine Biosciences Inc. has given to Indian investors in the last 5 years?
Neurocrine Biosciences Inc. stock has given 60.68% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?